Travere Therapeutics (NASDAQ:TVTX) Price Target Raised to $10.00 at Stifel Nicolaus
Travere Therapeutics (NASDAQ:TVTX – Free Report) had its target price boosted by Stifel Nicolaus from $8.00 to $10.00 in a research note issued to investors on Monday morning, Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock. Several other research firms have also recently commented on TVTX. Piper Sandler decreased their target […]
More Stories
What is a Policy Management System? 8 Best Policy Management Software
Are you also searching for software to automate your company’s policy? In this article, I’ll share details about the policy...
Murder of Renee Nicole Good Raised Questions on Trump’s Immigration Policy
Who is Renee Nicole Good? Why suddenly everyone’s eyes are on the US? Renee Nicole is a poet, writer, wife,...
Musk Says X’s New Algorithm Will Be Open Source in 6 Days
By Jacob Burg Elon Musk said on Jan. 10 that his X social media platform would open its new algorithm...
Trump Urges Cuba to Strike Deal With US After Oil, Money Cut Off From Venezuela
By Jacob Burg U.S. President Donald Trump on Jan. 11 told Cuba that it should forge a deal with the...
Wall Street Review: Stocks Close Out Strong Week on Labor Market Clarity
By Panos Mourdoukoutas Equities resumed their rally this week as investors gained a clearer view of the labor market following...
Protests Spread in Iran as Regime Vows to Retaliate Against Any US Attack
By Jacob Burg The Iranian regime threatened on Jan. 11 to strike Israeli and U.S. military bases if Washington attacks...